DCT

6:21-cv-00286

Fresenius Kabi v. Custopharm Inc

General
Filed
02/19/21
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (01/06/22)
Patent Owner
Operating Company (L)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
16%